Literature DB >> 22203236

Treatment of homonymous visual field defects.

Daniel R Gold1, Lori L Grover.   

Abstract

OPINION STATEMENT: A clinical presentation of a retrochiasmal or homonymous visual field defect (HVFD) usually represents a permanent visual impairment. The visual and functional ramifications of HVFD will vary by patient. Comprehensive care-the clinical evaluation and consideration for treatment of HVFD-includes vision rehabilitation provided by optometrists, occupational therapists, or ophthalmologists. On the basis of individual patient needs, the eye care practitioner typically uses one or both of the following approaches to treat the HVFD: (1) field enhancement (also referred to in the literature as "field expansion"), in which optical systems incorporating prism are prescribed to optimize the use of the remaining vision, and (2) rehabilitative techniques including saccadic training ("compensation training") or vision restorative therapy ("restitution training"). Although lacking in strength, the evidence does support benefits from field enhancement and saccadic training for patients with HVFD, but vision restorative therapy has not been shown to be an effective option.

Entities:  

Year:  2012        PMID: 22203236     DOI: 10.1007/s11940-011-0160-7

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  39 in total

1.  Disappointing results from Nova Vision's visual restoration therapy.

Authors:  J C Horton
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Homonymous hemianopias: clinical-anatomic correlations in 904 cases.

Authors:  X Zhang; S Kedar; M J Lynn; N J Newman; V Biousse
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

3.  Computer-based training for the treatment of partial blindness.

Authors:  E Kasten; S Wüst; W Behrens-Baumann; B A Sabel
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

4.  Rehabilitation of homonymous scotomata in patients with postgeniculate damage of the visual system: saccadic compensation training.

Authors:  G Kerkhoff; U Münßinger; E Haaf; G Eberle-Strauss; E Stögerer
Journal:  Restor Neurol Neurosci       Date:  1992-01-01       Impact factor: 2.406

5.  Eye movements in reading with hemianopic field defects: the significance of clinical parameters.

Authors:  S Trauzettel-Klosinski; K Brendler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-02       Impact factor: 3.117

6.  Field expansion for homonymous hemianopia by optically induced peripheral exotropia.

Authors:  E Peli
Journal:  Optom Vis Sci       Date:  2000-09       Impact factor: 1.973

7.  The relation between impairments and functional outcomes poststroke.

Authors:  A T Patel; P W Duncan; S M Lai; S Studenski
Journal:  Arch Phys Med Rehabil       Date:  2000-10       Impact factor: 3.966

8.  Saccadic eye movement strategies in patients with homonymous hemianopia.

Authors:  O Meienberg; W H Zangemeister; M Rosenberg; W F Hoyt; L Stark
Journal:  Ann Neurol       Date:  1981-06       Impact factor: 10.422

9.  Community-based trial of a peripheral prism visual field expansion device for hemianopia.

Authors:  Alex R Bowers; Karen Keeney; Eli Peli
Journal:  Arch Ophthalmol       Date:  2008-05

10.  Optokinetic therapy improves text reading in patients with hemianopic alexia: a controlled trial.

Authors:  G A Spitzyna; R J S Wise; S A McDonald; G T Plant; D Kidd; H Crewes; A P Leff
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

View more
  2 in total

1.  Neurorehabilitation of saccadic ocular movement in a patient with a homonymous hemianopia postgeniculate caused by an arteriovenous malformation: A Case Report.

Authors:  Mirna Pineda-Ortíz; Gustavo Pacheco-López; Moisés Rubio-Osornio; Carmen Rubio; Juan Valadez-Rodríguez
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

2.  Visual processing speed in hemianopia patients secondary to acquired brain injury: a new assessment methodology.

Authors:  Laura Mena-Garcia; Miguel J Maldonado-Lopez; Itziar Fernandez; Maria B Coco-Martin; Jaime Finat-Saez; Jose L Martinez-Jimenez; Jose C Pastor-Jimeno; Juan F Arenillas
Journal:  J Neuroeng Rehabil       Date:  2020-01-31       Impact factor: 4.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.